Floatz logo

Akkermansia Muciniphila

Prediabetes

Yu ChenN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

45 Active assets in the Prediabetes cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Semaglutide
The University of Texas Health Science Center at San Antonio
Phase 4BBB
Semaglutide
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BBB
Exenatide
RenJi Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Akkermansia Muciniphila is also rated in:

renal cell carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →